Trial Profile
Prasugrel in patients undergoing percutaneous coronary intervention : A real world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2016
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- Acronyms VA CART
- 24 Nov 2016 New trial record
- 01 Oct 2016 Results (n= 11617) published in the Clinical Cardiology.